Press Releases on August 5, 2024 - EIN Presswire - Press Release Distribution Service

Published on August 5, 2024 - 20:01 GMT

Praxis Precision Medicines to Announce Second Quarter 2024 Financial Results and Host Conference Call on Tuesday, August 13, 2024

BOSTON, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by …

Distribution channels:

Published on August 5, 2024 - 20:01 GMT

Capital Southwest Announces Financial Results for First Fiscal Quarter Ended June 30, 2024, Increases Regular Dividend to $0.58 ...

DALLAS, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the …

Distribution channels:

Published on August 5, 2024 - 20:01 GMT

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results

-More than 35 authorized treatment centers (ATCs) activated globally for CASGEVY™ and approximately 20 patients have had cells collected across all regions as of mid-July- -Clinical trials ongoing for next generation CAR T product candidates, CTX112™ and …

Distribution channels:

Published on August 5, 2024 - 20:01 GMT

HighPeak Energy, Inc. Announces Second Quarter 2024 Financial and Operating Results

FORT WORTH, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. (“HighPeak” or the “Company”) (NASDAQ: HPK) today announced financial and operating results for the quarter and the six months ended June 30, 2024, and provided updated 2024 …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 5, 2024 - 20:01 GMT

Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update

Enrollment concluded in the Phase 2a proof-of-concept clinical trial evaluating SPR720 in nontuberculous mycobacterial pulmonary disease (NTM-PD); preliminary data expected in 4Q 2024 New SPR720 in-vitro resistance data to be presented at IDWeek 2024 …

Distribution channels:

Published on August 5, 2024 - 20:01 GMT

Recursion to Report Second Quarter 2024 Business Updates and Financial Results on August 8th

Salt Lake City, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide business updates and report its Q2 2024 financial results …

Distribution channels:

Published on August 5, 2024 - 20:01 GMT

CSX Corp. Announces Second Quarter 2024 Results

JACKSONVILLE, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) today announced second quarter 2024 operating income of $1.45 billion compared to $1.47 billion in the prior year period. Net earnings were $963 million, or $0.49 per diluted …

Distribution channels: Business & Economy ...